Loading...
DOCUMENTS
20
NOTICES
33
MOTS CLES
DNA METHYLATION
Primary sclerosing cholangitis
Surgery
Vedolizumab
Tuberculosis
Dysbiose
Cancer
Microbiote
18 FDG-PET/CT
Résistance
Stricture
Crohn’s disease
Eligibility
RISK
Crohn's disease
Cell adhesion
Patients experience
Colon
Original Article Clinical
Survival
Intestinal crypts
Neoadjuvant chemotherapy
COLON-CANCER
Eradication
Inhibitor
Bacteria
Colectomy
Inflammatory Bowel Diseases
Tailored therapy
HIV
Ustekinumab
Venous thromboembolism
Biomarker
Patient-reported outcome
Epigenetics
Anti-TNF
Algorithm
Colorectal cancer Colibactin and lipids
Inflammatory bowel disease
Fecal microbiota
Colon cancer
Consensus
MARKER
Colorectal cancer
IBD
Thérapie ciblée
Clinical trial
MICROBIOTA
Genes
DNA methylation
Cost effectiveness
Immune cells
Colonic epithelial primary cells
Ulcerative colitis
T1118 translocation
Drug
Rituximab
Inflammatory bowel diseases
Disease progression
Upper gastrointestinal tract
Gene methylation
Therapeutics
IL23
Rituximab plus chlorambucil
Safety
Microbiota
Clinical guidelines
Disability
Small molecules
Epigénétiques
Biologics
PCR
Methylation
Contraindication
Acceptability
Over 80s
Endoscopic treatment
Méthylation
Kidney diseases
Gènes
Dysbiosis
Gene expression
Alkylating agents
Bactéries
Monitoring
Inclusion
CARCINOGENESIS
Helicobacter pylori
Effectiveness
MALT
Screening
Disease Progression
Maintenance therapy
Resistance
Immunosuppressant
Heart disease risk factors
MORTALITY
IL12
Parvimonas micra
Anti-TNF agents
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|